Market Place
Sourcing Support
Pharma stocks face Q4 reality check Amid Global Headwinds
20 Apr 2026 //
INDPHARMAPOST
AKCDA Treasurer Demands Antony Tharyan`s Resignation in Drug
14 Apr 2026 //
PHARMABIZ
Pharma Inc Urges Streamlined Regulatory Process For Growth Pill
09 Feb 2026 //
BUSINESS STD
Sun Pharma, Dr. Reddy`s, Lupin Advocate Major Drug Innovation
09 Feb 2026 //
ECONOMICTIMES
Cipla To Expand Domestic Market Focus On Chronic Therapies
27 Jan 2026 //
ECONOMICTIMES
Cipla Reports Consolidated PAT Of Rs. 675.80 Cr
24 Jan 2026 //
INDPHARMAPOST
National Pharmaceutical Pricing Authority Sets Retail Prices
27 Dec 2025 //
PHARMABIZ
Cipla Launches Inhalable Insulin For Diabetes Care
23 Dec 2025 //
ECONOMICTIMES
Cipla, Pfizer Partner For Exclusive Marketing Of 4 Brands
19 Dec 2025 //
ECONOMICTIMES
Cipla Introduces Yurpeak For Obesity, Type 2 Diabetes In India
10 Dec 2025 //
INDPHARMAPOST
Venus Remedies Receives Rs. 11 Crore Final Payment From Cipla
09 Dec 2025 //
INDPHARMAPOST
Cipla Launches India`s First Lung Health Diagnostics Center
28 Nov 2025 //
ECONOMICTIMES
Cipla USA Bolsters Lung Leadership Through Community Wellness
17 Nov 2025 //
PR NEWSWIRE
Cipla To Fully Acquire Inzpera Healthscience
03 Nov 2025 //
ECONOMICTIMES
Cipla Posts Consolidated Q2 FY26 PAT Rs. 1,351.17 Cr
02 Nov 2025 //
INDPHARMAPOST
Cipla Names Achin Gupta As MD & GCEO Effective April 1, 2026
30 Oct 2025 //
EXPRESSPHARMA
Lilly, Cipla Partner For Yurpeak Distribution In Weight Loss Drug
23 Oct 2025 //
ECONOMICTIMES
Cipla Launches HUENA, India`s First Non-Antibiotic UTI Treatment
06 Sep 2025 //
EXPRESSPHARMA
Cipla Expands Fall River Operations in USA, Plans to Hire
08 Aug 2025 //
PR NEWSWIRE
Cipla Targets $1 Bn Us Revenue in FY27
25 Jul 2025 //
ECONOMICTIMES
Cipla Health launches Astaberry`s campaign `Get the Rich Look`
17 Jul 2025 //
INDPHARMAPOST
Cipla in Talks to Add Customers for China Factory
02 Jul 2025 //
ECONOMICTIMES
Cipla Health launches campaign for Cipladine with Neena Gupta
13 Jun 2025 //
INDPHARMAPOST
Cipla names Prabhakaran Nair Global Chief Manufacturing Officer
03 Jun 2025 //
EXPRESSPHARMA
Cipla Partners American Lung Association for Champion
27 May 2025 //
PR NEWSWIRE
Cipla Launches Zemdri in India, Aims to Tackle AMR
21 May 2025 //
EXPRESSPHARMA
Cipla reports FY25 PAT higher 28.4% at Rs. 5,273 Cr
14 May 2025 //
INDPHARMAPOST
Indian pharma stocks `breathe easy` on US tariffs exemption
03 Apr 2025 //
REUTERS
Cipla and Formosa sign licensing deal for Clobetasol Suspension
18 Mar 2025 //
PR NEWSWIRE
Cipla CEO: Tariffs Should Not Dictate Indian Pharma Business
03 Mar 2025 //
ECONOMICTIMES
Cipla Beats Q3 Profit View as India Offsets Weak U.S. Sales
28 Jan 2025 //
REUTERS
Briefs: Cipla and IOL Chemicals and Pharmaceuticals
21 Jan 2025 //
INDPHARMAPOST
JPMorgan Sees Cipla Stock Upside With Gabraxane FDA Approval
31 Oct 2024 //
INVESTING
Cipla Q2 Profit Rises 15% to Rs 1,303 Cr, Revenue Up 5.6%
30 Oct 2024 //
BUSINESS STD
India`s Cipla beats Q2 profit view on strong US, India demand
29 Oct 2024 //
REUTERS
Cipla, Alkem Laboratories in final lap to buy SMT
16 Oct 2024 //
ECONOMICTIMES
Cipla Vice Chairman MK Hamied Resigns, Son Kamil Hamied Joins the Board
03 Sep 2024 //
ECONOMICTIMES
Cipla expects to commence supplies to US from China plant later this year
28 Jul 2024 //
ECONOMICTIMES
Cipla`s North America business revenue hits record high in Q1 at $250 million
26 Jul 2024 //
ECONOMICTIMES
Cipla gets Rs 773 crore demand notice from I-T department
17 Jul 2024 //
ECONOMIC TIMES
As monsoon sets in, respiratory, malaria drugs see demand rise
08 Jul 2024 //
ECONOMIC TIMES
DoP directs NPPA to recalculate ceiling price of three after Cipla`s petition
03 Jun 2024 //
PHARMABIZ
Indian drugmakers to see FY25 revenue boost in key US market
28 May 2024 //
REUTERS
Cipla ups investment in point-of-care testing firm Achira Labs
16 May 2024 //
ECONOMICTIMES
Cipla shares soar 4% after promoter family unloads 2.53% stake
15 May 2024 //
MONEYCONTROL
India`s Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
11 May 2024 //
REUTERS
Cipla beats estimates as Q4 net profit zooms 78% to Rs 939 crore
09 May 2024 //
MONEYCONTROL
Indian drugmaker Lupin misses quarterly profit estimates as costs rise
06 May 2024 //
REUTERS
Amgen reports a 22% increase in Q1 2024 net revenues
03 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Dr Reddy’s, Sun, Cipla and Biocon look to recreate Ozempic magic in India
28 Apr 2024 //
ECONOMICTIMES
Cipla Health strengthens its play in beauty and personal care
16 Apr 2024 //
INDIANPHARMAPOST
Sanofi India, Cipla join hands to promote CNS products in India
27 Mar 2024 //
BUSINESS STANDARD
Cipla incorporates JV company in USA
02 Mar 2024 //
INDIAN PHARMA POST
Cipla partners with CSIR-CDRI to develop formulation for fungal keratitis
15 Feb 2024 //
ECONOMIC TIMES
Cipla eyes acquisitions, inorganic partnerships in US market
04 Feb 2024 //
ECONOMIC TIMES
Cipla expects record 24 per cent Ebitda margin in FY24
26 Jan 2024 //
ECONOMIC TIMES
Samina Hamied of Cipla steps down from her executive role
26 Jan 2024 //
ECONOMIC TIMES
Cipla posts Q3 FY24 consolidated PAT at Rs. 1,055.90 Cr
23 Jan 2024 //
INDIAN PHARMA POST
Cipla announces joint venture in the United States with Kemwell Biopharma
08 Jan 2024 //
PR NEWSWIRE
Cipla invests Rs 42 crore in digital tech firm GoApptiv
15 Dec 2023 //
ECONOMIC TIMES
